Original article| Volume 30, ISSUE 4, P269-278, April 2008

Bilirubin encephalopathy: A study of neuronal subpopulations and neurodegenerative mechanisms in 12 autopsy cases


      Bilirubin encephalopathy (BE), which includes acute (kernicterus) and chronic (postkernicteric) forms, results from severe neonatal jaundice. In order to investigate neurodegenerative mechanisms in autopsy cases of BE, we immunohistochemically examined expressions of neurotransmitters, neuropeptides, and calcium-binding proteins in the basal ganglia; and deposition of oxidative products. Expression of tyrosine hydroxylase was reduced in the putamen in cases of acute BE, and in the globus pallidus in cases of acute and chronic postkernicteric BE. Methionine–enkephalin expression was reduced in the external segment of the globus pallidus in cases of acute and chronic postkernicteric BE, and immunoreactivity for substance P was severely altered in both internal and external segments in cases of chronic postkernicteric BE. A decrease in the number of parvalbumin-immunoreactive interneurons in the external segment of the globus pallidus was observed predominantly in cases of acute BE, whereas the number of interneurons immunoreactive for calbindin-D28K was reduced in the putamen in cases of chronic postkernicteric BE. Nuclear immunoreactivity for 8-hydroxy-2′-deoxyguanosine was seen in the putamen in half of the BE cases. These findings indicated that the putamen was impaired in BE and the pallidal external segment was also damaged in the acute form of BE, suggesting that oxidative damage to DNA is implicated in lesions of the basal ganglia.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Volpe J.J.
        Bilirubin and brain injury.
        in: Neurology of the newborn. 4th ed. Saunders, Philadelphia2001: 521-546
        • Friede R.L.
        Kernicterus (Bilirubin encephalopathy).
        in: Developmental neuropathology. 2nd ed. Springer-Verlag, Berlin1989: 113-124
        • Kinney H.C.
        • Armstrong D.D.
        Perinatal neuropathology.
        in: Graham D.I. Lantos P.L. Greenfield’s neuropathology. 6th ed. Arnold, London2002: 519-606
        • Hansen T.W.
        Bilirubin brain toxicity.
        J Perinatol. 2001; 21: 48-51
        • Shapiro S.M.
        Bilirubin toxicity in the developing nervous system.
        Pediatr Neurol. 2003; 29: 410-421
        • Falcão A.S.
        • Fernandes A.
        • Brito M.A.
        • Silva R.F.M.
        • Brites D.
        Bilirubin-induced immunostimulant effects and toxicity vary with neural cell type and maturation state.
        Acta Neuropathol. 2006; 112: 95-105
        • Hayashi M.
        • Araki S.
        • Kohyama J.
        • Shioda K.
        • Fukatsu R.
        • Tamagawa K.
        Brainstem and basal ganglia lesions in xeroderma pigmentosum group A.
        J Neuropathol Exp Neurol. 2004; 63: 1048-1057
        • Hayashi M.
        • Araki S.
        • Kohyama J.
        • Shioda K.
        • Fukatsu R.
        Oxidative nucleotide damage and superoxide dismutase expression in the brains of xeroderma pigmentosum group A and Cockayne syndrome.
        Brain Dev. 2005; 27: 34-38
        • Hayashi M.
        • Itoh M.
        • Araki S.
        • Kumada S.
        • Shioda K.
        • Tamagawa K.
        • et al.
        Oxidative stress and disturbed glutamate transport in hereditary nucleotide repair disorders.
        J Neuropathol Exp Neurol. 2001; 60: 350-356
        • Hedreen J.C.
        Tyrosine hydroxylase-immunoreactive elements in the human globus pallidus and subthalamic nucleus.
        J Comp Neurol. 1999; 409: 400-410
        • Prensa L.
        • Cossette M.
        • Parent A.
        Dopaminergic innervation of human basal ganglia.
        Chem Neuroanat. 2000; 20: 207-213
        • Brana C.
        • Charron G.
        • Aubert I.
        • Carles D.
        • Martin-Negrier M.L.
        • Trouette H.
        • et al.
        Ontogeny of the striatal neurons expressing neuropeptide genes in the human fetus and neonate.
        J Comp Neurol. 1995; 360: 488-505
        • Nakano K.
        • Katayama T.
        • Tsutsumi T.
        • Ushio H.
        Neural circuits and functional organization of the striatum.
        J Neurol. 2000; 247: 1-15
        • Cicchetti F.
        • Prensa L.
        • Wu Y.
        • Parent A.
        Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington’s disease.
        Brain Res Rev. 2000; 34: 80-101
        • Morel A.
        • Loup F.
        • Magnin M.
        • Jeanmonod D.
        Neurochemical organization of the human basal ganglia: anatomofunctional territories defined by the distributions of calcium-binding proteins and SMI-32.
        J Comp Neurol. 2002; 443: 86-103
        • Kalanithi P.S.
        • Zheng W.
        • Kataoka Y.
        • DiFiglia M.
        • Grantz H.
        • Saper C.B.
        • et al.
        Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome.
        Proc Natl Acad Sci USA. 2005; 102: 13307-13312
        • Johnston M.V.
        • Hoon A.H.
        Possible mechanisms in infants for selective basal ganglia damage from asphyxia, kernicterus, or mitochondrial encephalopathies.
        J Child Neurol. 2000; 15: 588-591
        • McDonald J.W.
        • Shapiro S.M.
        • Silverstein F.S.
        • Johnston M.V.
        Role of glutamate receptor-mediated excitotoxicity in bilirubin-induced brain injury in the Gunn rat model.
        Exp Neurol. 1998; 150: 21-29
        • Jellinger K.A.
        General aspects of neurodegeneration.
        J Neural Transm Suppl. 2003; 65: 101-144
        • Nunomura A.
        • Perry G.
        • Aliev G.
        • Hirai K.
        • Takeda A.
        • Balraj E.K.
        • et al.
        Oxidative damage is the earliest event in Alzheimer disease.
        J Neuropathol Exp Neurol. 2001; 60: 759-767
        • Jenner P.
        Oxidative stress in Parkinson’s disease.
        Ann Neurol. 2003; 53: 26-38
        • Toyokuni S.
        • Tanaka T.
        • Hattori Y.
        • Nishiyama Y.
        • Yoshida A.
        • Uchida K.
        • et al.
        Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model.
        Lab Invest. 1997; 76: 365-374